Obesity does not alter the pharmacokinetics of drotrecogin alfa (activated) in severe sepsis.

Author Department

Medicine

Document Type

Article, Peer-reviewed

Publication Date

2-1-2005

Abstract

BACKGROUND: Drotrecogin alfa (activated) [DrotAA] is approved for the reduction of mortality in adults with severe sepsis (sepsis with acute organ dysfunction) and high risk of death. Patients whose actual body weight was >135 kg were excluded from the

Publication ISSN

1073-449X

Share

COinS